A detailed history of Granite Fo LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Granite Fo LLC holds 590 shares of NVO stock, worth $66,050. This represents 0.04% of its overall portfolio holdings.

Number of Shares
590
Holding current value
$66,050
% of portfolio
0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$119.07 - $145.42 $70,251 - $85,797
590 New
590 $70.3 Million
Q1 2024

Sep 05, 2024

SELL
$102.11 - $135.92 $45,949 - $61,163
-450 Reduced 43.27%
590 $79.3 Million
Q4 2023

Sep 05, 2024

SELL
$87.78 - $105.45 $21,945 - $26,362
-250 Reduced 19.38%
1,040 $108 Million
Q3 2023

Sep 05, 2024

BUY
$90.94 - $199.54 $58,656 - $128,703
645 Added 100.0%
1,290 $117 Million
Q4 2022

Sep 05, 2024

BUY
$102.55 - $135.33 $66,144 - $87,287
645 New
645 $80.4 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Granite Fo LLC Portfolio

Follow Granite Fo LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Fo LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Fo LLC with notifications on news.